EFG
IDXX icon

Embree Financial Group’s Idexx Laboratories IDXX Stock Holding History

Embree Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
413
+36
+10% +$20.2K 0.02% 267
2026
Q1 		$212K Buy
+377
New +$242K 0.02% 249
2024
Q4 		– Sell
-428
Closed -$216K – 202
2024
Q3 		$216K Sell
428
-307
-42% -$149K 0.04% 179
2024
Q2 		$358K Hold
735
– – 0.07% 136
2024
Q1 		$397K Sell
735
-45
-6% -$24.6K 0.08% 132
2023
Q4 		$433K Buy
+780
New +$366K 0.09% 120

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Embree Financial Group's IDXX Position: Q2 2026 in Review

Embree Financial Group increased its Idexx Laboratories (IDXX) stake by 9.5% in Q2 2026, buying an estimated $20.2K and bringing the position to 413 shares worth $217K. The position accounts for 0.02% of the portfolio, ranked #267.

Embree Financial Group first reported a position in IDXX in Q4 2023 and has held it in 6 quarters since. The position peaked at $433K in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Embree Financial Group held 413 shares of Idexx Laboratories worth $217K as of Q2 2026.
  • Embree Financial Group bought 36 Idexx Laboratories shares in Q2 2026, an estimated $20.2K.
  • Idexx Laboratories made up 0.02% of Embree Financial Group's portfolio in Q2 2026, its #267 holding.
  • Embree Financial Group first reported a position in Idexx Laboratories in Q4 2023 and has held it in 6 quarters since.
  • Embree Financial Group's Idexx Laboratories position peaked at $433K in Q4 2023.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.